ABVC · Abvc Biopharma, Inc.
Market Cap
$23.46M
Shares
26.65M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 8-K | 2026-08-27 | — | |
| 8-K/A | 2026-08-12 | 2026-08-03 | |
| 10-Q | 2026-08-12 | 2026-06-30 | |
| 8-K | 2026-08-04 | 2026-08-03 | |
| 8-K | 2026-07-02 | — | |
| 10-Q | 2026-05-18 | 2026-03-31 | |
| 8-K | 2026-03-27 | — | |
| DEF 14A | 2026-03-05 | 2026-03-26 | |
| 10-K | 2026-03-03 | 2025-12-31 | |
| 10-Q/A | 2026-03-03 | 2025-09-30 | |
| 8-K | 2026-03-03 | — | |
| 8-K/A | 2026-01-16 | 2025-04-30 | |
| 10-Q | 2025-11-03 | 2025-09-30 | |
| 8-K | 2025-11-03 | — | |
| 8-K | 2025-10-30 | 2025-10-28 | |
| 8-K/A | 2025-09-12 | 2024-10-18 | |
| 8-K | 2025-08-14 | — | |
| 10-Q | 2025-08-13 | 2025-06-30 | |
| 8-K/A | 2025-07-18 | 2024-02-08 | |
| 8-K | 2025-06-04 | 2025-06-03 | |
| 8-K/A | 2025-05-30 | 2025-04-30 | |
| DEF 14A | 2025-05-16 | 2025-06-03 | |
| 8-K/A | 2025-05-14 | 2024-07-12 | |
| 8-K/A | 2025-05-14 | 2025-04-30 | |
| 8-K/A | 2025-05-06 | 2025-04-30 | |
| 8-K/A | 2025-05-02 | 2025-04-15 | |
| 8-K | 2025-05-01 | — | |
| 10-Q | 2025-04-30 | 2025-03-31 | |
| 8-K | 2025-04-30 | — | |
| 8-K/A | 2025-04-16 | 2025-04-15 | |
| 8-K | 2025-04-15 | — | |
| 10-K | 2025-04-15 | 2024-12-31 | |
| 8-K | 2025-03-07 | 2025-03-05 | |
| 8-K/A | 2025-01-13 | 2024-07-12 | |
| 8-K | 2025-01-06 | — | |
| 8-K | 2024-11-14 | — | |
| 10-Q | 2024-11-14 | 2024-09-30 | |
| 8-K | 2024-11-04 | — | |
| 8-K | 2024-10-18 | — | |
| 8-K | 2024-09-10 | — | |
| 8-K | 2024-08-20 | — | |
| 8-K | 2024-08-15 | — | |
| 10-Q | 2024-08-14 | 2024-06-30 | |
| 8-K | 2024-07-23 | — | |
| 8-K | 2024-07-12 | — | |
| 8-K/A | 2024-06-25 | 2023-11-16 | |
| 8-K/A | 2024-06-24 | 2024-03-26 | |
| 8-K | 2024-05-24 | — | |
| 8-K | 2024-05-23 | — | |
| 10-Q | 2024-05-17 | 2024-03-31 |
Showing 1–50 of 144 filings